Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Enrofloxacin | Enrofloxacin EP Impurity A | VL3550003 | View |
Enrofloxacin | Enrofloxacin EP Impurity B | VL3550001 | View CAS 85721-33-1 |
Enrofloxacin | Enrofloxacin EP Impurity C | VL3550002 | View |
Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Enrofloxacin | Enrofloxacin EP Impurity A | VL3550003 | View |
Enrofloxacin | Enrofloxacin EP Impurity B | VL3550001 | View CAS 85721-33-1 |
Enrofloxacin | Enrofloxacin EP Impurity C | VL3550002 | View |
Catalogue No. | VL3550001 |
CAS No. | 85721-33-1 |
Molecular Formula | C17H18FN3O3 |
Molecular Weight | 331.34 |
Parent drug | Enrofloxacin |
IUPAC Name | 1-Cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid |
Synonyms | Ciprofloxacin; Ciprine; Cipro IV |
References | Lizondo, Mònica, et al. “Physicochemical Properties of Enrofloxacin.” Journal of Pharmaceutical and Biomedical Analysis, vol. 15, no. 12, Aug. 1997, pp. 1845–49, https://doi.org/10.1016/s0731-7085(96)02033-x. |
Status | In-stock |
ListName | Enrofloxacin EP Impurity B |
Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields